Two Blokes

FDA investigates patient deaths after treatment with Sarepta's gene therapy

  • click to rate
    Posted by Two Blokes Jun 24 - Filed in Stock - 2 views
    The U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver failure in non-ambulatory Duchenne muscular dystrophy patients after receiving Sarepta Therapeutics' gene therapy, Elevidys.